"You don't see that in any of the other core photos"
Have they shown photos of all the holes they have drilled?
"And ofc spodumene and lepidolite can both be light purple"
In pegmatites, 99 times out of 100, purple will mean lepidolite although not all lepidolite is purple. The 1 out of 100 times will be where you could get purple-coloured spodumene, referred to as kunzite in the gem community, but I wouldn't expect to see this outside of Brazil or the Afghanistan region. (credit @Son of Gwalia)
"Not really anything to be concerned about"
Disagree, fact is the photo I posted shows that lepidolite is present in the system. If its a significant part of the quoted Li results reported, then these theoretically need to be adjusted to account for the lepidolite. That they continuously refer to "spodumene observed" doesn't mean there isn't also lepidolite associated with these intersections. Until detailed mineralogy is provided one can't simply assume that its not an issue.
- Forums
- ASX - By Stock
- WR1
- Ann: Assays confirm Adina as a robust, high-grade lithium project
Ann: Assays confirm Adina as a robust, high-grade lithium project, page-113
-
- There are more pages in this discussion • 413 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WR1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
69.0¢ |
Change
-0.040(5.48%) |
Mkt cap ! $151.4M |
Open | High | Low | Value | Volume |
73.0¢ | 73.0¢ | 69.0¢ | $312.7K | 442.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 39840 | 69.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
69.5¢ | 5239 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 43617 | 0.690 |
1 | 4050 | 0.685 |
7 | 46720 | 0.680 |
3 | 27393 | 0.675 |
3 | 100226 | 0.670 |
Price($) | Vol. | No. |
---|---|---|
0.695 | 5639 | 8 |
0.700 | 3460 | 4 |
0.705 | 22442 | 2 |
0.710 | 1600 | 1 |
0.715 | 2716 | 1 |
Last trade - 14.56pm 15/07/2024 (20 minute delay) ? |
Featured News
WR1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online